Pages that link to "Q40213326"
Jump to navigation
Jump to search
The following pages link to Antimüllerian hormone levels are lower in BRCA2 mutation carriers (Q40213326):
Displaying 8 items.
- Fertility preservation in BRCA-mutated women: when and how? (Q47554393) (← links)
- Association of Mutations and Anti-müllerian Hormone Level in Young Breast Cancer Patients (Q64054701) (← links)
- Navigating the body of literature assessing BRCA1/2 mutations and markers of ovarian function: a systematic review and meta-analysis (Q90647977) (← links)
- Fertility preservation in gynecologic cancers (Q90661129) (← links)
- Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer (Q92225038) (← links)
- Clinical application of serum anti-Müllerian hormone in women (Q92637333) (← links)
- Crosstalk between PTEN/PI3K/Akt Signalling and DNA Damage in the Oocyte: Implications for Primordial Follicle Activation, Oocyte Quality and Ageing (Q92702430) (← links)
- Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1 (Q92736434) (← links)